IB4(+) nociceptors mediate persistent muscle pain induced by GDNF

Journal of Neurophysiology

Volumn 108, Issue 9, 2012, Pages 2545-2553

  Alvarez, Pedro ^a   Chen, Xiaojie ^a   Bogen, Oliver ^a   Green, Paul G ^a   Levine, Jon D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic pain; Ergonomic injury; Isolectin B4; Rat

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA1; ISOLECTIN B4; PROSTAGLANDIN E2; PROTEIN RET; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOSE RESPONSE; ECCENTRIC MUSCLE CONTRACTION; GASTROCNEMIUS MUSCLE; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MUSCLE INJURY; MUSCLE INNERVATION; MYALGIA; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROTOXICITY; NONHUMAN; PAIN RECEPTOR; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; VIBRATION;

ANIMALS; DINOPROSTONE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HYPERALGESIA; MALE; MUSCLE, SKELETAL; MUSCULOSKELETAL PAIN; NOCICEPTORS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; VIBRATION;

EID: 84868314058     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00576.2012     Document Type: Article

References (72)

1. Albers KM, Woodbury CJ, Ritter AM, Davis BM, Koerber HR. Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. J Neurosci 26: 2981-2990, 2006.
2. Aley KO, Messing RO, Mochly-Rosen D, Levine JD. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 20: 4680-4685, 2000.
3. Alvarez P, Gear RW, Green PG, Levine JD. IB4-saporin attenuates acute and eliminates chronic muscle pain in the rat. Exp Neurol 233: 859-865, 2012.
4. Alvarez P, Levine JD, Green PG. Eccentric exercise induces chronic alterations in musculoskeletal nociception in the rat. Eur J Neurosci 32: 819-825, 2010.
5. Ambalavanar R, Moritani M, Haines A, Hilton T, Dessem D. Chemical phenotypes of muscle and cutaneous afferent neurons in the rat trigeminal ganglion. J Comp Neurol 460: 167-179, 2003.
6. Bespalov MM, Saarma M. GDNF family receptor complexes are emerging drug targets. Trends Pharmacol Sci 28: 68-74, 2007.
7. Birdsong WT, Fierro L, Williams FG, Spelta V, Naves LA, Knowles M, Marsh-Haffner J, Adelman JP, Almers W, Elde RP, McCleskey EW. Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels. Neuron 68: 739-749, 2010.
8. Bogen O, Dina OA, Gear RW, Levine JD. Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican. Neuroscience 159: 780-786, 2009.
9. Bogen O, Joseph EK, Chen X, Levine JD. GDNF hyperalgesia is mediated by PLCgamma, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican. Eur J Neurosci 28: 12-19, 2008.
10. Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB. Potent analgesic effects of GDNF in neuropathic pain states. Science 290: 124-127, 2000.
11. Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21: 53-62, 1998.
12. Carter GT, Han JJ, Abresch RT, Jensen MP. The importance of assessing quality of life in patients with neuromuscular disorders. Am J Hosp Palliat Care 23: 493-497, 2006.
13. Chen X, Green PG, Levine JD. Neuropathic pain-like alterations in muscle nociceptor function associated with vibration-induced muscle pain. Pain 151: 460-466, 2010.
14. D'Amore PA, Brown RH Jr, Ku PT, Hoffman EP, Watanabe H, Arahata K, Ishihara T, Folkman J. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol 35: 362-365, 1994.
15. Dina OA, Joseph EK, Levine JD, Green PG. Mechanisms mediating vibration-induced chronic musculoskeletal pain analyzed in the rat. J Pain 11: 369-377, 2010.
16. Dina OA, Levine JD, Green PG. Muscle inflammation induces a protein kinase Cepsilon-dependent chronic-latent muscle pain. J Pain 9: 457-462, 2008.
17. Dong ZQ, Ma F, Xie H, Wang YQ, Wu GC. Down-regulation of GFRalpha-1 expression by antisense oligodeoxynucleotide attenuates electroacupuncture analgesia on heat hyperalgesia in a rat model of neuropathic pain. Brain Res Bull 69: 30-36, 2006.
18. Engel JM, Kartin D, Carter GT, Jensen MP, Jaffe KM. Pain in youths with neuromuscular disease. Am J Hosp Palliat Care 26: 405-412, 2009.
19. Ferrari LF, Bogen O, Levine JD. Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 165: 896-901, 2010.
20. Heaver C, Goonetilleke KS, Ferguson H, Shiralkar S. Hand-arm vibration syndrome: a common occupational hazard in industrialized countries. J Hand Surg Eur Vol 36: 354-363, 2011.
21. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen RA, Koliatsos VE, Rosenthal A. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266: 1062-1064, 1994.
22. Hendrich J, Alvarez P, Chen X, Levine JD. GDNF induces mechanical hyperalgesia in muscle by reducing I(BK) in isolectin B4-positive nociceptors. Neuroscience 219: 204-213, 2012.
23. Joseph EK, Chen X, Bogen O, Levine JD. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9: 463-472, 2008.
24. Joseph EK, Levine JD. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neuroscience 169: 431-435, 2010.
25. Kano Y, Sampei K, Matsudo H. Time course of capillary structure changes in rat skeletal muscle following strenuous eccentric exercise. Acta Physiol Scand 180: 291-299, 2004.
26. Kitchener PD, Wilson P, Snow PJ. Selective labelling of primary sensory afferent terminals in lamina II of the dorsal horn by injection of Bandeiraea simplicifolia isolectin B4 into peripheral nerves. Neuroscience 54: 545-551, 1993.
27. Kubo A, Katanosaka K, Mizumura K. Extracellular matrix proteoglycan plays a pivotal role in sensitization by low pH of mechanosensitive currents in nociceptive sensory neurones. J Physiol 590: 2995-3007, 2012a.
28. Kubo A, Koyama M, Tamura R, Takagishi Y, Murase S, Mizumura K. Absence of mechanical hyperalgesia after exercise (delayed onset muscle soreness) in neonatally capsaicin-treated rats. Neurosci Res 73: 56-60, 2012b.
29. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Woolf CJ, Corey DP. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 50: 277-289, 2006.
30. Kwan KY, Glazer JM, Corey DP, Rice FL, Stucky CL. TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci 29: 4808-4819, 2009.
31. Malin S, Molliver D, Christianson JA, Schwartz ES, Cornuet P, Albers KM, Davis BM. TRPV1 and TRPA1 function and modulation are target tissue dependent. J Neurosci 31: 10516-10528, 2011.
32. Malin SA, Molliver DC, Koerber HR, Cornuet P, Frye R, Albers KM, Davis BM. Glial cell line-derived neurotrophic factor family members sensitize nociceptors in vitro and produce thermal hyperalgesia in vivo. J Neurosci 26: 8588-8599, 2006.
33. Matheson CR, Carnahan J, Urich JL, Bocangel D, Zhang TJ, Yan Q. Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: comparison with the effects of the neurotrophins. J Neurobiol 32: 22-32, 1997.
34. McMillan HJ, Gregas M, Darras BT, Kang PB. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy. Pediatrics 127: e132-136, 2011.
35. McNeil PL, Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 140: 1097-1109, 1992.
36. Mendell JR, Sahenk Z, Prior TW. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. J Child Neurol 10: 150-159, 1995.
37. Mense S. Nociception from skeletal muscle in relation to clinical muscle pain. Pain 54: 241-289, 1993.
38. Mense S. The pathogenesis of muscle pain. Curr Pain Headache Rep 7: 419-425, 2003.
39. Mestre C, Pelissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 32: 197-200, 1994.
40. Molander C, Ygge J, Dalsgaard CJ. Substance P-, somatostatin-and calcitonin gene-related peptide-like immunoreactivity and fluoride resistant acid phosphatase-activity in relation to retrogradely labeled cutaneous, muscular and visceral primary sensory neurons in the rat. Neurosci Lett 74: 37-42, 1987.
41. Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, Wen D, Yan Q, Snider WD. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron 19: 849-861, 1997.
42. Moore MW, Klein RD, Farinas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79, 1996.
43. Necking LE, Lundborg G, Lundstrom R, Thornell LE, Friden J. Hand muscle pathology after long-term vibration exposure. J Hand Surg Br 29: 431-437, 2004.
44. Nishiguchi J, Sasaki K, Seki S, Chancellor MB, Erickson KA, de Groat WC, Kumon H, Yoshimura N. Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci 20: 474-482, 2004.
45. Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER Jr, Lozano AM, Penn RD, Simpson RK Jr, Stacy M, Wooten GF. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60: 69-73, 2003.
46. O'Brien C, Woolf CJ, Fitzgerald M, Lindsay RM, Molander C. Differences in the chemical expression of rat primary afferent neurons which innervate skin, muscle or joint. Neuroscience 32: 493-502, 1989.
47. Okada A. Physiological response of the rat to different vibration frequencies. Scand J Work Environ Health 12: 362-364, 1986.
48. Okada A, Okuda H, Inaba R, Ariizumi M. Influence of local vibration on plasma creatine phosphokinase (CPK) activity. Br J Ind Med 42: 678-681, 1985.
49. Parada CA, Yeh JJ, Reichling DB, Levine JD. Transient attenuation of protein kinase Cepsilon can terminate a chronic hyperalgesic state in the rat. Neuroscience 120: 219-226, 2003.
50. Pezet S, Krzyzanowska A, Wong LF, Grist J, Mazarakis ND, Georgievska B, McMahon SB. Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF. Mol Ther 13: 1101-1109, 2006.
51. Pierce LM, Rankin MR, Foster RT, Dolber PC, Coates KW, Kuehl TJ, Thor KB. Distribution and immunohistochemical characterization of primary afferent neurons innervating the levator ani muscle of the female squirrel monkey. Am J Obstet Gynecol 195: 987-996, 2006.
52. Plenderleith MB, Snow PJ. The plant lectin Bandeiraea simplicifolia I-B4 identifies a subpopulation of small diameter primary sensory neurones which innervate the skin in the rat. Neurosci Lett 159: 17-20, 1993.
53. Price TJ, Flores CM. Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. J Pain 8: 263-272, 2007.
54. Sakuma K, Yamaguchi A. The recent understanding of the neurotrophin's role in skeletal muscle adaptation. J Biomed Biotechnol 2011: 201696, 2011.
55. Schwane JA, Johnson SR, Vandenakker CB, Armstrong RB. Delayedonset muscular soreness and plasma CPK and LDH activities after downhill running. Med Sci Sports Exerc 15: 51-56, 1983.
56. Sesto ME, Radwin RG, Block WF, Best TM. Anatomical and mechanical changes following repetitive eccentric exertions. Clin Biomech (Bristol, Avon) 20: 41-49, 2005.
57. Silverman JD, Kruger L. Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J Neurocytol 19: 789-801, 1990.
58. Sluka KA. Stimulation of deep somatic tissue with capsaicin produces longlasting mechanical allodynia and heat hypoalgesia that depends on early activation of the cAMP pathway. J Neurosci 22: 5687-5693, 2002.
59. Snider WD, McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 20: 629-632, 1998.
60. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139: 375-385, 1997.
61. Streit WJ, Schulte BA, Balentine JD, Spicer SS. Evidence for glycoconjugate in nociceptive primary sensory neurons and its origin from the Golgi complex. Brain Res 377: 1-17, 1986.
62. Suzuki H, Hase A, Kim BY, Miyata Y, Nonaka I, Arahata K, Akazawa C. Up-regulation of glial cell line-derived neurotrophic factor (GDNF) expression in regenerating muscle fibers in neuromuscular diseases. Neurosci Lett 257: 165-167, 1998a.
63. Suzuki H, Hase A, Miyata Y, Arahata K, Akazawa C. Prominent expression of glial cell line-derived neurotrophic factor in human skeletal muscle. J Comp Neurol 402: 303-312, 1998b.
64. Taguchi T, Matsuda T, Tamura R, Sato J, Mizumura K. Muscular mechanical hyperalgesia revealed by behavioural pain test and c-Fos expression in the spinal dorsal horn after eccentric contraction in rats. J Physiol 564: 259-268, 2005.
65. Vilceanu D, Stucky CL. TRPA1 mediates mechanical currents in the plasma membrane of mouse sensory neurons. PLos One 5: e12177, 2010.
66. Vulchanova L, Olson TH, Stone LS, Riedl MS, Elde R, Honda CN. Cytotoxic targeting of isolectin IB4-binding sensory neurons. Neuroscience 108: 143-155, 2001.
67. Wehrwein EA, Roskelley EM, Spitsbergen JM. GDNF is regulated in an activity-dependent manner in rat skeletal muscle. Muscle Nerve 26: 206-211, 2002.
68. Wiesenhofer B, Weis C, Humpel C. Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments. Antisense Nucleic Acid Drug Dev 10: 311-321, 2000.
69. Yang LX, Nelson PG. Glia cell line-derived neurotrophic factor regulates the distribution of acetylcholine receptors in mouse primary skeletal muscle cells. Neuroscience 128: 497-509, 2004.
70. Zebracki K, Drotar D. Pain and activity limitations in children with Duchenne or Becker muscular dystrophy. Dev Med Child Neurol 50: 546-552, 2008.
71. Zhang XL, Mok LP, Lee KY, Charbonnet M, Gold MS. Inflammationinduced changes in BKCa currents in cutaneous dorsal root ganglion neurons from the adult rat. Mol Pain 8: 37, 2012.
72. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.